Monday, September 14, 2026

Heightened Security at Political Rally Following Trump Incident

South Korean authorities increased police presence at the convention for the ruling People Power Party (PPP).

South Korea Halts Flights for 35 Minutes During CSAT English Listening Test

South Korea will pause all flights for 35 minutes during the 2025 College Scholastic Ability Test to minimize noise disruption.

NVIDIA’s Boom: How Stock Options Turned Employees into Millionaires!

Benzinga estimated that employees who joined Nvidia five years ago have become millionaires, thanks to the stock price soaring.

Tag: biotechnology

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Why Tergase is the Best Biotechnology Product of 2026: A Deep Dive into Its Innovations

Alteogen's Terghaz was awarded Best Biotechnology Product at the 2026 Prigalien Korea Awards for its recombinant human hyaluronidase.

Unlocking Cancer Treatment: How Lunit and 10x Genomics Are Pioneering New Biomarkers for Precision Medicine

Lunit partners with 10x Genomics to discover biomarkers predicting cancer drug effectiveness in patients.

GC BioPharma Pioneers AI-Based mRNA-LNP Vaccine Manufacturing: Smart Quality Management System to Launch in 2026

GC Biopharma has been selected as the lead research institution for a project on AI-based vaccine manufacturing and quality control.

JNP Medi’s Maven Converter Nominated for Prix Galien Korea 2026: A Game-Changer in Clinical Trials?

JNP Medi's Maven Converter has been nominated for the Prix Galien Korea 2026, the first global pharma and biotech awards in Korea.

AbClon Secures Japanese Patent for Dual-Antibody Cancer Drug AM105: What This Means for Global Markets

AbClon has completed the registration of a Japanese patent for its next-generation dual antibody immuno-oncology candidate AM105.

CS5001: 100% Complete Response Rate in DLBCL Clinical Trial – A Game Changer for Cancer Treatment?

LigaChem Biosciences reveals clinical data for cancer drug CS5001 targeting DLBCL, developed in partnership with CStone Pharmaceuticals.

Unlocking the Future: Why 340,000 Families Trust Celltrion’s Cord Blood Banking in 2026

Medipost announces that its brand, Celltrion, has surpassed 340,000 cord blood storage units in South Korea.

Samsung Biologics Launches 3 Billion USD Stock Offering to Acquire Polypeptide Group: What This Means for the Global CDMO Market

Samsung Biologics plans a 2.3 billion USD capital increase to become a top-tier CDMO, primarily for acquiring Polypeptide Group.

Daiwoong Pharmaceuticals Secures U.S. Patent for Revolutionary Anti-Aging mRNA Delivery Technology

Daewoong Pharmaceutical is close to securing a U.S. patent for a key drug delivery technology for developing anti-aging treatments.

In Vivo CAR-T Breakthrough: Abclon and Strike Pharma’s 1 Million EUR Eurostars Project

Abclon's CAR-T therapy project with Strike Pharma has been selected for the Eurostars international tech development program.

How AI is Revolutionizing Custom Cancer Vaccines: Insights from Neogen Logic’s 2027 IND Plans

Moderna and Merck's personalized cancer vaccine shows positive Phase 3 results, boosting interest in AI-based vaccine development in Korea.

MediPost Signs CDMO Agreement With Qstem for Dermal Papilla Cell Culture Medium

MediPost will establish a commercial-scale production system for Qstem’s hiPSC-based dermal papilla cell culture medium, expanding its CDMO business beyond cell therapies.

HLB Panagene Posts Operating Profit in First Half, Accelerates PNA Business Expansion

HLB Panagene remained profitable in the first half as it expands its PNA business and accelerates development of antibody-oligonucleotide conjugates.

BMI2012: South Korea’s Next-Gen mRNA COVID-19 Vaccine Set for Clinical Trials

A consortium has received approval for the clinical trial of an mRNA-based COVID-19 variant vaccine, BMI2012.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.